← All news

Insights

Africa's most populous country invests in cancer biobanking

Nigeria's NICRAT and BioVana Research are establishing a National Cancer Biobank Network connecting eight centres across the country's six geopolitical zones.

Nigeria builds a national cancer biobank network: 200M+ people, 8 centres, 6 geopolitical zones.

Nigeria, Africa's most populous country with well over 200 million people, is taking a significant step toward building its own cancer research infrastructure. The National Institute for Cancer Research and Treatment (NICRAT) is working with Nigerian/US company BioVana Research to establish a National Cancer Biobank Network (NCBN) connecting eight centres across the country's six geopolitical zones.

NICRAT has set out five priorities for the network: governance, quality standards, ethical safeguards, data management and sustainable financing.

With such a large and genetically diverse population, still underrepresented in global cancer research, the network could support genomic studies, clinical trials and precision oncology that generate evidence directly relevant to Nigerian patients. As always with multicentre biobanking, success will depend on harmonised procedures for collecting, preserving, documenting and sharing samples across sites.

An initiative worth following for anyone working in oncology, biobanking or global health.